Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Accuray Incorporated ARAY
$3.55
-$0.09 (-2.61%)
На 18:00, 12 мая 2023
+97.18%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
349988090.00000000
-
week52high
3.74
-
week52low
1.70
-
Revenue
429909000
-
P/E TTM
-33
-
Beta
1.50484400
-
EPS
-0.11000000
-
Last Dividend
0.00000000
-
Next Earnings Date
26 апр 2023 г. в 20:30
Описание компании
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body, such as prostate, lung, brain, spine, liver, pancreas, and kidney. The company also provides the TomoTherapy System, including the Radixact System, which consists of an integrated radiation therapy system designed for the treatment of a range of cancer types. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Sunnyvale, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| B. Riley Securities | Buy | 31 авг 2022 г. | |
| BTIG | Buy | Buy | 24 июн 2022 г. |
| B. Riley Securities | Buy | 23 июн 2022 г. | |
| Loop Capital | Buy | 22 дек 2021 г. | |
| BTIG Research | Buy | Neutral | 21 янв 2020 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Pervaiz Ali | D | 408492 | 2053 | 04 янв 2023 г. |
| Spine Patrick | D | 208561 | 5176 | 01 дек 2022 г. |
| Chew Jesse | D | 246480 | 5976 | 01 дек 2022 г. |
| Winter Suzanne C | D | 721758 | 9823 | 01 дек 2022 г. |
| Hoge Michael | D | 286373 | 5531 | 01 дек 2022 г. |
| Spine Patrick | A | 385721 | 88580 | 30 ноя 2022 г. |
| Spine Patrick | A | 297141 | 88580 | 30 ноя 2022 г. |
| Pervaiz Ali | A | 410545 | 118110 | 30 ноя 2022 г. |
| Pervaiz Ali | A | 292435 | 118110 | 30 ноя 2022 г. |
| Winter Suzanne C | A | 1509158 | 393700 | 30 ноя 2022 г. |
Новостная лента
Accuray (ARAY) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks Investment Research
26 апр 2023 г. в 22:45
Although the revenue and EPS for Accuray (ARAY) give a sense of how its business performed in the quarter ended March 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Accuray (ARAY) Q3 Earnings and Revenues Beat Estimates
Zacks Investment Research
26 апр 2023 г. в 19:45
Accuray (ARAY) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to loss of $0.01 per share a year ago.
Here's Why You Should Retain Accuray (ARAY) Stock for Now
Zacks Investment Research
20 мар 2023 г. в 09:59
Investors continue to be optimistic about Accuray (ARAY) owing to strong demand for its products.
3 Cutting-Edge Healthcare Stocks That Can Pay Off Big Time
InvestorPlace
18 мар 2023 г. в 19:18
Healthcare costs in America and the world are set to rise in the foreseeable future. All thanks to an aging population, and the expectation that healthcare companies will be able to cure more of our diseases.
Accuray (ARAY) Q2 Earnings and Revenues Top Estimates
Zacks Investment Research
02 февр 2023 г. в 18:04
Despite solid product demand, Accuray (ARAY) reports an overall soft fiscal Q2 performance.